{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:34:46Z","timestamp":1787319286577,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T00:00:00Z","timestamp":1413936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00210-014-1056-3","type":"journal-article","created":{"date-parts":[[2014,10,21]],"date-time":"2014-10-21T23:47:25Z","timestamp":1413935245000},"page":"43-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Effects of opioids on human serotonin transporters"],"prefix":"10.1007","volume":"388","author":[{"given":"M.","family":"Barann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U. M.","family":"Stamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lyutenska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"St\u00fcber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"B\u00f6nisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,22]]},"reference":[{"key":"1056_CR1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2710.2007.00813.x","volume":"32","author":"S Ailawadhi","year":"2007","unstructured":"Ailawadhi S, Sung KW, Carlson LA, Baer MR (2007) Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther 32:199\u2013202. doi: 10.1111\/j.1365-2710.2007.00813.x","journal-title":"J Clin Pharm Ther"},{"key":"1056_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10620-009-0711-x","volume":"55","author":"AA Alkhatib","year":"2010","unstructured":"Alkhatib AA, Peterson KA, Tuteja AK (2010) Serotonin syndrome as a complication of fentanyl sedation during esophagogastroduodenoscopy. Dig Dis Sci 55:215\u2013216. doi: 10.1007\/s10620-009-0711-x","journal-title":"Dig Dis Sci"},{"key":"1056_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s002100000288","volume":"362","author":"M Barann","year":"2000","unstructured":"Barann M, Meder W, Dorner Z, Br\u00fcss M, B\u00f6nisch H, G\u00f6thert M, Urban BW (2000) Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects. Naunyn Schmiedebergs Arch Pharmacol 362:255\u2013265","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1056_CR4","first-page":"253","volume":"58","author":"M Barann","year":"2006","unstructured":"Barann M, Br\u00fcss M, Brinkmann M, Linden I, Lyutenska M, Schneider M, Walkembach J, Wittmann M (2006a) 5-HT3 receptors and emesis. Pharmacol Rep 58:253\u2013255","journal-title":"Pharmacol Rep"},{"key":"1056_CR5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2005.11.054","volume":"531","author":"M Barann","year":"2006","unstructured":"Barann M, Urban B, Stamer U, Dorner Z, B\u00f6nisch H, Br\u00fcss M (2006b) Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis. Eur J Pharmacol 531:54\u201358. doi: 10.1016\/j.ejphar.2005.11.054","journal-title":"Eur J Pharmacol"},{"key":"1056_CR6","first-page":"309","volume":"62","author":"D Bijl","year":"2004","unstructured":"Bijl D (2004) The serotonin syndrome. Neth J Med 62:309\u2013313","journal-title":"Neth J Med"},{"key":"1056_CR7","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","volume":"352","author":"EW Boyer","year":"2005","unstructured":"Boyer EW, Shannon M (2005) The serotonin syndrome. N Engl J Med 352:1112\u20131120. doi: 10.1056\/NEJMra041867","journal-title":"N Engl J Med"},{"key":"1056_CR8","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/MCB.7.8.2745","volume":"7","author":"C Chen","year":"1987","unstructured":"Chen C, Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745\u20132752. doi: 10.1128\/MCB.7.8.2745","journal-title":"Mol Cell Biol"},{"key":"1056_CR9","first-page":"645","volume":"31","author":"Z Fisar","year":"2010","unstructured":"Fisar Z, Hroudov\u00e1 J, Raboch J (2010) Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. Neuro Endocrinol Lett 31:645\u2013656","journal-title":"Neuro Endocrinol Lett"},{"key":"1056_CR10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/bja\/aei210","volume":"95","author":"PK Gillman","year":"2005","unstructured":"Gillman PK (2005) Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth 95:434\u2013441. doi: 10.1093\/bja\/aei210","journal-title":"Br J Anaesth"},{"key":"1056_CR11","unstructured":"Gillman PK. (2014) Monoamine oxydase inhibitors, opiate analgesics and serotonin toxicity. Available: http:\/\/www.psychotropical.com\/index.php\/moi-oa-st . Accessed 30 March 2014. doi 10.1093\/bja\/aei210 . PMID: 16051647"},{"key":"1056_CR12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jclinane.2011.04.017","volume":"24","author":"S Gollapudy","year":"2012","unstructured":"Gollapudy S, Kumar V, Dhamee MS (2012) A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion. J Clin Anesth 24:251\u2013252. doi: 10.1016\/j.jclinane.2011.04.017","journal-title":"J Clin Anesth"},{"key":"1056_CR13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2125.1999.00986.x","volume":"48","author":"S Grond","year":"1999","unstructured":"Grond S, Meuser T, Uragg H, Stahlberg HJ, Lehmann KA (1999) Serum concentrations of tramadol enantiomers during patient-controlled analgesia. Br J Clin Pharmacol 48:254\u2013257. doi: 10.1046\/j.1365-2125.1999.00986.x","journal-title":"Br J Clin Pharmacol"},{"key":"1056_CR14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/ALN.0b013e3182a76d05","volume":"120","author":"C Jeleazcov","year":"2012","unstructured":"Jeleazcov C, Saari TI, Ihmsen H, Mell J, Fr\u00f6hlich K, Krajinovic L, Fechner J, Sch\u00fcttler J (2012) Population pharmacokinetic modeling of hydromorphone in cardiac surgery patients during postoperative pain therapy. Anesthesiology 120:378\u2013391. doi: 10.1097\/ALN.0b013e3182a76d05","journal-title":"Anesthesiology"},{"key":"1056_CR15","first-page":"513","volume":"39","author":"H Jellinek","year":"1990","unstructured":"Jellinek H, Haumer H, Grubhofer G, Klappacher G, Jenny T, Weindlmayr-Goettel M, Fitzal S (1990) Tramadol in postoperative pain therapy. Patient-controlled analgesia versus continuous infusion. Anaesthesist 39:513\u2013520","journal-title":"Anaesthesist"},{"key":"1056_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1213\/00000539-198101000-00002","volume":"60","author":"AJ Koska","year":"1981","unstructured":"Koska AJ, Kramer WG, Romagnoli A, Keats AS, Sabawala PB (1981) Pharmacokinetics of high-dose meperidine in surgical patients. Anesth Analg 60:8\u201311","journal-title":"Anesth Analg"},{"key":"1056_CR17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00002508-199009000-00008","volume":"6","author":"KA Lehmann","year":"1990","unstructured":"Lehmann KA, Kratzenberg TP, Schroeder-Bark B, Horrichs-Haermeyer G (1990) Postoperative patient-controlled analgesia with tramadol. Analgesic efficacy and minimum effective concentrations. Clin J Pain 6:212\u2013220","journal-title":"Clin J Pain"},{"key":"1056_CR18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","volume":"66","author":"MJ Millan","year":"2002","unstructured":"Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355\u2013474. doi: 10.1016\/S0301-0082(02)00009-6","journal-title":"Prog Neurobiol"},{"key":"1056_CR19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1119(03)00503-1","volume":"310","author":"B Niesler","year":"2003","unstructured":"Niesler B, Frank B, Kapeller J, Rappold GA (2003) Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 310:101\u2013111. doi: 10.1016\/S0378-1119(03)00503-1","journal-title":"Gene"},{"key":"1056_CR20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bmj.1.5272.151","volume":"1","author":"JF O\u2019Sullivan","year":"1962","unstructured":"O\u2019Sullivan JF (1962) Analgesia for forceps delivery. A technique for the \u201csingle-handed\u201d obstetrician. Br Med J 1:151\u2013152","journal-title":"Br Med J"},{"key":"1056_CR21","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000542-199406000-00014","volume":"80","author":"MJ Paech","year":"1994","unstructured":"Paech MJ, Moore JS, Evans SF (1994) Meperidine for patient-controlled analgesia after cesarean section. Intravenous versus epidural administration. Anesthesiology 80:1268\u20131276","journal-title":"Anesthesiology"},{"key":"1056_CR22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12028-013-9914-2","volume":"21","author":"S Pedavally","year":"2014","unstructured":"Pedavally S, Fugate JE, Rabinstein AA (2014) Serotonin syndrome in the intensive care unit: clinical presentations and precipitating medications. Neurocrit Care 21:108\u2013113. doi: 10.1007\/s12028-013-9914-2","journal-title":"Neurocrit Care"},{"key":"1056_CR23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF03016672","volume":"55","author":"ST Rang","year":"2008","unstructured":"Rang ST, Field J, Irving C (2008) Serotonin toxicity caused by an interaction between fentanyl and paroxetine. Can J Anaesth 55:521\u2013625. doi: 10.1007\/BF03016672","journal-title":"Can J Anaesth"},{"key":"1056_CR24","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/ALN.0b013e31823940c0","volume":"115","author":"R Rastogi","year":"2008","unstructured":"Rastogi R, Swarm RA, Patel TA (2008) Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiology 115:1291\u20131298. doi: 10.1097\/ALN.0b013e31823940c0","journal-title":"Anesthesiology"},{"key":"1056_CR25","first-page":"282","volume-title":"Anesthesia","author":"JG Reves","year":"2011","unstructured":"Reves JG, Glas P, Lubarsky DA (2011) Nonbarbiturate intravenous anesthetics. In: Miller RD, Cuchiara RF, Miller ED, Reves JG, Roizen MF, Savarese JJ (eds) Anesthesia. Churchill Livingston, Philadelphia, pp 282\u2013372"},{"key":"1056_CR26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/026988119801200201","volume":"12","author":"P Schloss","year":"1998","unstructured":"Schloss P, Williams DC (1998) The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 12:115\u2013121. doi: 10.1177\/026988119801200201","journal-title":"J Psychopharmacol"},{"key":"1056_CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11916-006-0020-4","volume":"10","author":"C Sommer","year":"2006","unstructured":"Sommer C (2006) Is serotonin hyperalgesic or analgesic? Curr Pain Headache Rep 10:101\u2013106","journal-title":"Curr Pain Headache Rep"},{"key":"1056_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.clpt.6100152","volume":"82","author":"UM Stamer","year":"2007","unstructured":"Stamer UM, Musshoff F, Kobilay M, Madea B, Hoeft A, Stuber F (2007) Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes. Clin Pharmacol Ther 82:1\u20137. doi: 10.1038\/sj.clpt.6100152","journal-title":"Clin Pharmacol Ther"},{"key":"1056_CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1517\/14740338.7.5.587","volume":"7","author":"C Sun-Edelstein","year":"2008","unstructured":"Sun-Edelstein C, Tepper SJ, Shapiro R (2008) Drug-induced serotonin syndrome: a review. Expert Opin Drug Saf 7:87\u201396. doi: 10.1517\/14740338.7.5.587","journal-title":"Expert Opin Drug Saf"},{"key":"1056_CR30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.pharmthera.2005.12.005","volume":"111","author":"BW Urban","year":"2006","unstructured":"Urban BW, Bleckwenn M, Barann M (2006) Interactions of anesthetics with their targets: non-specific, specific or both? Pharmacol Ther 111:729\u2013770. doi: 10.1016\/j.pharmthera.2005.12.005","journal-title":"Pharmacol Ther"},{"key":"1056_CR31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00000542-198003000-00008","volume":"52","author":"PF White","year":"1980","unstructured":"White PF, Way WL, Trevor AJ (1980) Pharmacology of ketamine isomers in surgical patients. Anesthesiology 52:231\u2013239","journal-title":"Anesthesiology"},{"key":"1056_CR32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1213\/01.ane.0000229706.84471.4d","volume":"103","author":"M Wittmann","year":"2006","unstructured":"Wittmann M, Peters I, Schaaf T, Wartenberg HC, Wirz S, Nadstawek J, Urban BW, Barann M (2006) The effects of morphine on human 5-HT3A receptors. Anesth Analg 103:747\u2013752. doi: 10.1213\/01.ane.0000229706.84471.4d","journal-title":"Anesth Analg"},{"key":"1056_CR33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1213\/ane.0b013e31817342c2","volume":"107","author":"M Wittmann","year":"2008","unstructured":"Wittmann M, Schaaf T, Peters I, Wirz S, Urban BW, Barann M (2008) The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors. Anesth Analg 107:107\u2013112. doi: 10.1213\/ane.0b013e31817342c2","journal-title":"Anesth Analg"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-014-1056-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-014-1056-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-014-1056-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T06:52:39Z","timestamp":1650437559000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-014-1056-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,22]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1007\/s00210-014-1056-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,22]]}}}